Study finds 1.5 percent ruxolitinib cream safe, effective for teens with eczema
Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD),…
Bringing News as it Unfolds
Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD),…